Financials in USD. Standardized financial statements.
A compact view of how Phibro Animal Health Corporation turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $1.30B | $1.02B | $977.89M | $942.26M | $833.35M | $800.35M | $828.00M | $820.00M | $764.30M | $751.50M |
| Revenue Growth? | +27.4% | +4.1% | +3.8% | +13.1% | +4.1% | -3.3% | +1.0% | +7.3% | +1.7% | 0.0% |
| Cost of Revenue? | $896.27M | $704.59M | $679.65M | $656.86M | $561.97M | $543.47M | $563.40M | $553.10M | $516.00M | $512.50M |
| Gross Profit? | $399.94M | $313.09M | $298.24M | $285.40M | $271.38M | $256.88M | $264.60M | $266.90M | $248.30M | $239.00M |
| Gross Margin? | +30.9% | +30.8% | +30.5% | +30.3% | +32.6% | +32.1% | +32.0% | +32.5% | +32.5% | +31.8% |
| Operating Expenses? | $289.48M | $259.78M | $226.39M | $206.41M | $196.51M | $187.69M | $181.40M | $168.00M | $150.30M | $153.30M |
| Operating Income? | $110.47M | $53.31M | $71.85M | $78.99M | $74.87M | $69.19M | $73.30M | $98.90M | $97.90M | $85.70M |
| EBITDA? | $146.85M | $69.06M | $106.03M | $117.13M | $110.21M | $101.58M | $112.75M | $128.62M | $123.42M | $117.06M |
| Income Before Tax | $67.99M | $10.92M | $54.07M | $72.33M | $66.47M | $55.51M | $71.50M | $88.10M | $80.50M | $76.80M |
| Income Tax Expense | $19.73M | $8.50M | $21.46M | $23.15M | $12.08M | $21.96M | $16.80M | $23.20M | $15.90M | -$6.00M |
| Net Income? | $48.26M | $2.42M | $32.61M | $49.17M | $54.38M | $33.55M | $54.70M | $64.90M | $64.60M | $82.70M |
| EPS? | $1.19 | $0.06 | $0.81 | $1.21 | $1.34 | $0.83 | $1.35 | $1.61 | $1.63 | $2.11 |
| Diluted EPS? | $1.19 | $0.06 | $0.81 | $1.21 | $1.34 | $0.83 | $1.35 | $1.61 | $1.61 | $2.07 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality